Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Narin Sheri

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 30, 2023
In Vivo Evaluation of Exon 51 Skipping in hDMD/Dmd-null MiceNarin Sheri, Toshifumi Yokota
Genes|October 29, 2025
Inherited Retinal Diseases with High Myopia: A ReviewCyndy Liu, Narin Sheri, Matthew D Benson
Ophthalmic Genetics|March 18, 2026
A heterozygous pathogenic <i>RPE65</i> variant phenocopies a mitochondrial retinopathyBrandon C Huynh, Narin Sheri, Matthew D Benson
Protein Science : a Publication of the Protein Society|January 22, 2025
Human recombinant tyrosinase destabilization caused by the double mutation R217Q/R402QSarah Toay, Narin Sheri, Ian MacDonald, et al.
Genes|July 12, 2020
Cardiac Involvement in Dystrophin-Deficient Females: Current Understanding and Implications for the Treatment of DystrophinopathiesKenji Rowel Q Lim, Narin Sheri, Quynh Nguyen, et al.
Ophthalmic Genetics|February 29, 2024
Novel heterozygous <i>PRPH2</i> variant identified in a patient with spinocerebellar ataxia type 14 and macular dystrophyTugche S Chen, Narin Sheri, David S Ehmann, et al.
Nucleic Acids Research|June 9, 2021
eSkip-Finder: a machine learning-based web application and database to identify the optimal sequences of antisense oligonucleotides for exon skippingShuntaro Chiba, Kenji Rowel Q Lim, Narin Sheri, et al.
Investigative Ophthalmology & Visual Science|September 23, 2025
RPE65 Variant p.(E519K) Causes a Novel Dominant Adult-Onset Maculopathy in 83 Affected IndividualsEline Van Vooren, Filip Van Den Broeck, Quinten Mahieu, et al.
Research Square|May 19, 2025
RPE65 variant p.(E519K) causes a novel dominant adult-onset maculopathy in 83 affected individualsEline Van Vooren, Filip Van den Broeck, Quinten Mahieu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|March 30, 2023
In Vivo Evaluation of Exon 51 Skipping in hDMD/Dmd-null MiceNarin Sheri, Toshifumi Yokota
Genes|October 29, 2025
Inherited Retinal Diseases with High Myopia: A ReviewCyndy Liu, Narin Sheri, Matthew D Benson
Ophthalmic Genetics|March 18, 2026
A heterozygous pathogenic <i>RPE65</i> variant phenocopies a mitochondrial retinopathyBrandon C Huynh, Narin Sheri, Matthew D Benson
Protein Science : a Publication of the Protein Society|January 22, 2025
Human recombinant tyrosinase destabilization caused by the double mutation R217Q/R402QSarah Toay, Narin Sheri, Ian MacDonald, et al.
Genes|July 12, 2020
Cardiac Involvement in Dystrophin-Deficient Females: Current Understanding and Implications for the Treatment of DystrophinopathiesKenji Rowel Q Lim, Narin Sheri, Quynh Nguyen, et al.
Ophthalmic Genetics|February 29, 2024
Novel heterozygous <i>PRPH2</i> variant identified in a patient with spinocerebellar ataxia type 14 and macular dystrophyTugche S Chen, Narin Sheri, David S Ehmann, et al.
Nucleic Acids Research|June 9, 2021
eSkip-Finder: a machine learning-based web application and database to identify the optimal sequences of antisense oligonucleotides for exon skippingShuntaro Chiba, Kenji Rowel Q Lim, Narin Sheri, et al.
Investigative Ophthalmology & Visual Science|September 23, 2025
RPE65 Variant p.(E519K) Causes a Novel Dominant Adult-Onset Maculopathy in 83 Affected IndividualsEline Van Vooren, Filip Van Den Broeck, Quinten Mahieu, et al.
Research Square|May 19, 2025
RPE65 variant p.(E519K) causes a novel dominant adult-onset maculopathy in 83 affected individualsEline Van Vooren, Filip Van den Broeck, Quinten Mahieu, et al.
Pageof 1